Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348026A2 Fibrin binding moieties useful as imaging agents
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1348021A2 25206, a novel human short-chain dehydrogenase/reductase family member and uses thereof
10/01/2003EP1347993A2 Superficial zone protein and methods of making and using same
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs
10/01/2003EP1347953A2 Agents and methods for promoting bone growth
10/01/2003EP1347783A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units
10/01/2003EP1347774A2 Modulation of cell growth by inhibiting binding of kringle 2 domain of plasminogen
10/01/2003EP1347773A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
10/01/2003EP1347772A2 Educated nk t cells and their uses in the treatment of immune-related disorders
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP1056467B1 Method for the treatment of diseases or disorders of the inner ear
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003EP0999825B1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP0946589B1 Inhibitors of peptide binding to mhc class ii proteins
10/01/2003EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/01/2003EP0912612B1 Simplified production of bispecific antibody fragments
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003EP0863917B1 Targeted cytotoxic anthracycline analogs
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446230A Peptide and peptide mimetic derivatives with integrin inhibitor preperties Ôàí"
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446105A Medicinal compositions for angiogenic therapy
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
10/01/2003CN1446100A Method for treating movement disorder
10/01/2003CN1446099A Remedies for chronic hepatitis B
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446096A Treatment of hepatitis C with thymosin, interferon and ribavirin
10/01/2003CN1446084A Treatment of insulin resistance syndrome
10/01/2003CN1446081A 神经毒素植入物 Neurotoxin implants
10/01/2003CN1446077A Inhaleable spray dried 4-holix bundle protein powders having minimized aggregation
10/01/2003CN1445366A New protein kinase specific to human cardiac muscle and its coded sequence
10/01/2003CN1445365A Method for preparing algin lyase and its application
10/01/2003CN1445364A Live scorpion enzyme and its preparing method
10/01/2003CN1445240A Killer cell antibiosis polypeptide activated by lymphokine and its application
10/01/2003CN1445239A Mutain of human stem cell growth fcator as well as its preparing method and medicine combination
10/01/2003CN1445238A Conformation type peptide library based on insect alexins, its constitute method and application
10/01/2003CN1445237A Anagonism peptide of tumor necrosis factor and its application
10/01/2003CN1444993A Application of the recombination human interferon omega in preparing medicine for preventing and treating not typical model pneumonia
10/01/2003CN1444992A Method and combination for treating tumors based on ERBB-3
10/01/2003CN1444991A Preparing method and usage of cardiotoxin
10/01/2003CN1122719C Modified biological material
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/01/2003CN1122716C Extracorporeal ceel culture and transplantation kits
10/01/2003CN1122534C Method for reducing side effects of drug
10/01/2003CN1122530C Vacines
10/01/2003CN1122529C Biological diatetic health-care food containing metallic sulfure protein for diabetes and complication and preparation method
09/2003
09/30/2003US6627798 Nucleotide sequences coding polypeptide associated with tyrosine biosynthesis for use in generation of amplified tyrosine concentration in plants
09/30/2003US6627769 Antiproliferative agents
09/30/2003US6627754 Pyrrolo[2,3-d]pyrimidine compounds
09/30/2003US6627746 DNA comprising nucleotide sequences that code for somatomedins and peptide domains
09/30/2003US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it
09/30/2003US6627740 Monoclonol antibody which binds to a polypeptide having pre-B cell growth supporting ability
09/30/2003US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease
09/30/2003US6627738 No-modified hemoglobins and uses therefor
09/30/2003US6627735 Islet cell antigen 1851
09/30/2003US6627733 Receptor tyrosine kinase with a discoidin-type binding domain
09/30/2003US6627732 Enhanced hematopoiesis promoting effect
09/30/2003US6627731 Thrombin derived polypeptides; compositions and methods for use
09/30/2003US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance
09/30/2003US6627729 TML peptides
09/30/2003US6627625 Beta-lactam antibiotics and beta -lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidenced inter by anxiolytic and antiaggressive behavior modification ans enhanced cognition
09/30/2003US6627619 Cancer diagnosis
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627610 Treat a viral infection in a subject via inhibiting the prenylation of a protein contained in the virus infecting said subject, which method comprises administering to said subject an agent selected from the group consisting of amino
09/30/2003US6627609 Peptides which contain N-methylated amino acid units and have improved water solubility. Medicaments in which the peptides according to the invention are contained can be used for the treatment of hormone- dependent tumours and
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627604 Memno peptides, process for their preparation and use thereof
09/30/2003US6627602 Preventing desensitization of receptors
09/30/2003US6627601 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier
09/30/2003US6627440 Recombinant human alpha-fetoprotein as a cell proliferative agent
09/30/2003US6627438 Nucleotide sequences for use in the generation of amidated peptides
09/30/2003US6627425 Human glucose-6-phosphatase molecules and uses thereof
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627403 Detecting hyperplasia in tissue sample; obtain tissue sample, isolate nucleotide sequence, detect chymotryptic nucleotide sequences, presence of sequences indicates hyperplasia
09/30/2003US6627213 Administering on the same day the infant is fed human breast milk a supplement free of carbohydrate and comprising casein, salts of casein, whey, and casein hydrolysates; decrease of jaundice and increase of excretion of bilirubin
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627198 Therapy, prevention tuberculosis infections
09/30/2003US6627197 Selective destruction of cells infected with human immunodeficiency virus
09/30/2003US6627196 Dosages for treatment with anti-ErbB2 antibodies
09/30/2003US6627195 Binding agents to CD23
09/30/2003US6627194 Activated immunoglobulin
09/30/2003US6627193 Contacting medium with arginine-specific cysteine proteinase of bacterial origin to produce activated Protein C
09/30/2003US6627189 Supressing expression of human p21 K-ras oncogene
09/30/2003US6627187 Containing an amino acid as a stabilizer; long term storage stability
09/30/2003US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF)
09/30/2003US6626982 Compound storage
09/30/2003CA2262465C Neuritin, a neurogene